AstraZeneca (AZN, Financials) said Monday it will invest $50 billion in the United States by 2030 to expand manufacturing and ...

AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...

Pharmaceutical stocks are in focus as President Trump's drug tariff deadline looms. Yahoo Finance Senior Reporter Anjalee ...

AstraZeneca unveils a $50 billion U.S. manufacturing expansion plan, anchored by a Virginia facility to boost drug output and ...

So hardly any stocks are moving lower, and those that are aren't seeing much volume, which can turn into a "sign of excessive bullishness," Thrasher said. At extremes, it turns into a sort-of ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

U.S. stocks appear set for a weak opening on Tuesday as investors exercise caution after the Trump administration said more ...

AstraZeneca said Tuesday it's planning to invest $50 billion in expanding its manufacturing and research presence in the U.S.

Adding to the string of US and international drugmakers investment in US production investment following a call from ...

The announcement comes as the Trump administration carries out a Section 232 probe to determine which drug manufacturers are ...

British-Swiss pharma giant AstraZeneca ($AZN) has committed to a $50 billion investment in the U.S. by 2030. The news follows ...

The biopharmaceutical company said the investment includes plans for a new manufacturing center focused on chronic diseases.